Alkazemi, M. H., Ostrovnaya, I., Zhang, A., Wald, G., Hernandez, C., Ghasemzadeh, A., Farha, M., Norton, R., Tomberlin, M., McCarter, M., Zagajeski, P., Hildreth, K., Al-Ahmadie, H., Goh, A. C., Bochner, B. H., Baig, M., Rosenberg, J. E., Iyer, G., Pietzak, E. J. (2026). Chemoablation with oral erdafitinib in recurrent
                    <i>FGFR3</i>
                    -altered non–muscle-invasive bladder cancer: A phase II window-of-opportunity trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4623